Roche Holding AG (RHHBF) 은(는) 상장 기업입니다 헬스케어 섹터의 제약 산업에서 운영. 본사 소재지는 Basel, 스위스. 현재 CEO는 Thomas Schinecker.
RHHBF 을(를) 보유 IPO 날짜 2012-08-03, 103,249 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $333.13B.
Roche Holding AG is a Swiss-based pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, immunology, cardiovascular, ophthalmology, and respiratory diseases, as well as treatments for conditions such as cancer, hemophilia, and inflammatory disorders. Roche also operates a substantial diagnostics business providing in vitro testing for disease diagnosis, including cancer, diabetes, COVID-19, and hepatitis, alongside diagnostic instruments and reagents. With operations spanning Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and other international markets, Roche maintains research collaborations to develop innovative therapies, including synthetic biologics for inflammatory bowel disease treatment.
